If the kidney and mesothelioma trials are a success on those...

If the kidney and mesothelioma trials are a success on those indications alone I reckon the stock's worth $300m. And the drug's likely to be used for many other cancers so conservatively another $100m. If anti anxiety shows promise that's another $100m within a year IMO - given massive market potential for partner. That's total of $500m.

We dont know yet if either will work, but strong promise already. Divide the above by three for the risk and we get ~$170m. That's what I reckon it should be worth today, but very little marketing leaves it undervalued.

If anti anxiety works should be worth ~$300m in three years' time to BNO, billions to partner.

Anyone disagree?